119.04USD+0.08%Mkt Cap: 15.85B USDP/E: —Last update: 2026-05-26
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutati…
Industry Peers
Diagnostics & Research166.94BUSDP/E 24.7
122.72BUSDP/E 33.6
44.05BUSDP/E 41.1
34.33BCHFP/E 37.8
33.46BUSDP/E 43.3
32.69BUSDP/E 25.5
28.46BUSD—
27.28BUSDP/E 20.3
Indicators:|
Key Statistics
Company
Market Cap15.85B USD
Enterprise Value16.25B USD
Revenue (TTM)1.08B USD
Gross Profit633.01M USD
Net Income (TTM)-416.28M USD
Revenue/Share8.491 USD
Last Price119.04 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.5K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS40131M1099
Valuation
P/E (Trailing)—
P/E (Forward)-191.26
PEG—
EV/EBITDA-39.81
EV/Revenue15.04
P/S14.49
P/B-85.70
EPS (TTM)-3.40
EPS (Forward)-0.62
52W Range
36.3698% of range121.01
52W High121.01 USD
52W Low36.36 USD
Profitability
Gross Margin64.46%
Oper. Margin-40.23%
EBITDA Margin-37.79%
Profit Margin-42.39%
ROE419.18%
ROA-20.67%
Growth
Revenue Growth48.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-184.76M USD
CapEx (TTM)48.31M USD
FCF Margin-7.91%
FCF Yield-0.54%
Net Debt601.80M USD
Net Debt/EBITDA-1.47
Balance Sheet
Debt/Equity-17.22
Current Ratio4.68
Quick Ratio4.25
Book Value/Sh-1.3770 USD
Cash/Share8.316 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)130.52 USD
Target Range90.00 USD – 190.00 USD
# Analysts21
Ownership
Shares Out.132.60M
Float127.57M
Insiders4.05%
Institutions105.79%
Short Interest
Short Ratio5.7d
Short % Float10.07%
Short % Out.9.66%
Shares Short12.81M
Short (prev mo.)13.70M
Technical
SMA 5090.47 (+31.6%)
SMA 20087.32 (+36.3%)
Beta1.49
S&P 52W Chg28.31%
Avg Vol (30d)2.12M
Avg Vol (10d)2.46M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—